| Literature DB >> 28560681 |
María José Serrano1,2, María Jesús Alvarez-Cubero3, Diego De Miguel Pérez3,4, Alba Rodríguez-Martínez3,4, Lucas Gonzalez-Herrera3,4, Inmaculada Robles-Fernandez3, José Exposito Hernandez5, Jose Luis García Puche3, José Antonio Lorente3,4.
Abstract
This chapter focuses on a deep description of the epidermal growth factor receptor (EGFR) expression in circulating tumor cells (CTCs) and its main role in cancer progression, genetic changes related to metastasis , and resistance to treatment. The aberrant behavior of cancer cells is caused by genetic mutations and altered patterns of gene expression. These changes can be responsible for an increase in cell motility but also an ability of CTCs to survival in different microenvironments, as well as developing therapy-resistant clones. Finally, CTCs can acquire the ability to invade distant organs, where metastatic foci can develop.Entities:
Keywords: Circulating tumor cells (CTCs); Dormancy; Epidermal growth factor receptor (EGFR); Epithelial mesenchymal transition (EMT); Invasion; Migration; Mutations; Resistant clones
Mesh：
Substances：
Year: 2017 PMID： 28560681 DOI： 10.1007/978-3-319-55947-6_16
Source DB: PubMed Journal: Adv Exp Med Biol ISSN： 0065-2598 Impact factor: 2.622